Cost-benefit issues in U.S. national health legislation: the case of the End-Stage Renal Disease Program.
D003362:Cost-Benefit Analysis; D003695:Delivery of Health Care; D004467:Economics; D005069:Evaluation Studies as Topic; D035082:Federal Government; D005378:Financial Support; D005380:Financing, Government; D006076:Government; D015276:Health Care Rationing; D006801:Humans; D007668:Kidney; D007674:Kidney Diseases; D016377:Organ Transplantation; D005791:Patient Care; D018579:Patient Selection; D010820:Physicians; D011379:Prognosis; D011640:Public Policy; D011788:Quality of Life; D006435:Renal Dialysis; D040841:Resource Allocation; D013223:Statistics as Topic; D014481:United States
End Stage Renal Disease Program; Health Care and Public Health